why choose us

First received: April 21, 2025

Clinical Trial: Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Brief Summary: A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Read more